With the analysis among 1,566 patents, we discovered top 315 key players by total patent application. Genentech, Inc., Celgene Corp., F. Hoffmann-La Roche Ltd. are dominant in this area. They take 11.43% of the total patent filing.
California, United States
Patent: 65
New Jersey, United States
Patent: 59
F. Hoffmann-La Roche Ltd.
California, United States
Patent: 48
Berlin, Germany
Patent: 41
Massachusetts, United States
Patent: 36
Cancer Research Ventures Ltd.
California, United States
Patent: 32
Shenzhen Chipscreen Biosciences Co., Ltd.
Guangdong Sheng, China
Patent: 28
With the analysis among 65 patents, we discovered top 12 start-ups by total patent application. Autolus Ltd., Institut National de la Santé et de la Recherche Médicale, ALX Oncology, Inc. are active in this area.
Institut National de la Santé et de la Recherche Médicale
California, United States
Patent: 4
Stemirna Therapeutics Co. Ltd.
Shanghai Shi, China
Patent: 3
Basel-Stadt, Switzerland
Patent: 2
Zug, Switzerland
Patent: 2
Beijing Geneplus Technology Co., Ltd.
Beijing Shi, China
Patent: 1
Beijing Shi, China
Patent: 1
Starton Therapeutics, Inc.
New York, United States
Patent: 1
With the analysis among related 1,002 patents applied in the last 5 years. We discover 312 most active companies in this area. The fast-growing F. Hoffmann-La Roche Ltd., Genentech, Inc., Cancer Research Ventures Ltd. take 11.58% of patent filing during this period.
F. Hoffmann-La Roche Ltd.
California, United States
Patent: 39
Cancer Research Ventures Ltd.
California, United States
Patent: 32
Institute Of Cancer Research
Shenzhen Chipscreen Biosciences Co., Ltd.
Guangdong Sheng, China
Patent: 28
Dana-Farber Cancer Institute, Inc.
Massachusetts, United States
Patent: 22
California, United States
Patent: 21
Hovedstaden, Denmark
Patent: 21
CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co., Ltd.
Hebei Sheng, China
Patent: 20
With the analysis among related 1,002 patents in last 5 years, we discover 224 new entrants. Cancer Research Ventures Ltd., Kite Pharma, Inc., Institute Of Cancer Research are the most active new entrants in this area.
Cancer Research Ventures Ltd.
California, United States
Patent: 32
Institute Of Cancer Research
Shenzhen Chipscreen Biosciences Co., Ltd.
Guangdong Sheng, China
Patent: 28
California, United States
Patent: 21
CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co., Ltd.
Hebei Sheng, China
Patent: 20
Charité - Universitätsmedizin Berlin
Berlin, Germany
Patent: 16
Cellular Biomedicine Group, Inc.
California, United States
Patent: 15
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 15
With the analysis among 382 patents, we discovered top 91 universities and scientific research institutions by total patent application. Institute Of Cancer Research, Charité - Universitätsmedizin Berlin, University of Barcelona are dominant in this area. They take 23.82% of the total patent filing.
Institute Of Cancer Research
Charité - Universitätsmedizin Berlin
Berlin, Germany
Patent: 16
Icahn School of Medicine at Mount Sinai
New York, United States
Patent: 8
New York, United States
Patent: 7
Illinois, United States
Patent: 7
University of British Columbia
British Columbia, Canada
Patent: 6
Nebraska, United States
Patent: 6
North Carolina, United States
Patent: 5
The Rockefeller University
New York, United States
Patent: 5